Ontario Institute for Cancer Research
Other Public Service · FY2025
114 disclosed employees* in 2025
16 yrs on file (2010–2025)
50.0% estimated female
Avg. salary
$154,906
Avg. total comp
$155,724
Total disclosed salary*
$17,659,329
⇄ Compare this employer with…
Total disclosed salary & employees over time 2010–2025
Total disclosed salary
Disclosed employees
Top positions FY2025 · ranked by disclosed employees
| # | Position | Disclosed Emp. | Median salary | P90 salary | Raise |
|---|---|---|---|---|---|
| 1 | Senior Manager province-wide | 10 | $123,895 | $129,384 | +1.3% |
| 2 | Director province-wide | 9 | $170,510 | $190,430 | +7.9% |
| 3 | Senior Scientist province-wide | 9 | $122,923 | $128,989 | +4.1% |
| 4 | Scientist province-wide | 7 | $135,582 | $141,795 | +7.5% |
| 5 | Systems Administrator province-wide | 4 | $109,564 | $117,858 | n/a |
| 6 | Program Manager province-wide | 3 | $118,641 | $134,419 | +3.3% |
| 7 | CFO province-wide | 1 | $319,995 | $319,995 | n/a |
| 8 | Executive Director province-wide | 1 | $158,539 | $158,539 | n/a |
| 9 | President province-wide | 1 | $539,745 | $539,745 | n/a |
| 10 | Team Lead province-wide | 1 | $128,287 | $128,287 | n/a |
Workforce history 2010–2025
| Year | Disclosed Emp. | Avg. salary | Avg. total comp | Total disclosed salary | Newly disclosed | Gender |
|---|---|---|---|---|---|---|
| 2025 | 114 | $154,906 | $155,724 | $17,659,329 | 11.4% | 50.0% F |
| 2024 | 109 | $157,054 | $157,854 | $17,118,838 | 14.7% | 49.5% F |
| 2023 | 97 | $159,306 | $160,133 | $15,452,690 | 17.5% | 50.5% F |
| 2022 | 86 | $161,329 | $162,096 | $13,874,274 | 15.1% | 53.5% F |
| 2021 | 83 | $156,879 | $157,551 | $13,020,921 | 10.8% | 49.4% F |
| 2020 | 83 | $163,937 | $164,589 | $13,606,753 | 26.5% | 44.6% F |
| 2019 | 67 | $158,187 | $158,848 | $10,598,504 | 20.9% | 41.8% F |
| 2018 | 57 | $161,382 | $162,042 | $9,198,747 | 12.3% | 43.9% F |
| 2017 | 57 | $164,654 | $165,295 | $9,385,253 | 17.5% | 45.6% F |
| 2016 | 54 | $171,623 | $172,247 | $9,267,631 | 20.4% | 37.0% F |
| 2015 | 48 | $187,733 | $188,387 | $9,011,204 | 12.5% | 31.2% F |
| 2014 | 48 | $187,267 | $187,920 | $8,988,833 | 16.7% | 35.4% F |
| 2013 | 51 | $186,255 | $186,907 | $9,498,997 | 13.7% | 41.2% F |
| 2012 | 54 | $174,483 | $174,959 | $9,422,059 | 22.2% | 40.7% F |
| 2011 | 43 | $171,589 | $172,089 | $7,378,306 | 16.3% | 41.9% F |
| 2010 | 38 | $171,666 | $172,176 | $6,523,294 | 100.0% | 42.1% F |
"Newly disclosed" is the share of that year's disclosed employees appearing on the list for the first time anywhere — not a hire rate. Many already worked here and simply crossed the $100,000 threshold. Gender is a name-based estimate, shown only for years with 20 or more disclosed employees.
Top disclosed earners FY2025
| # | Name | Title | Total comp | YoY | Sector rank | Position rank |
|---|---|---|---|---|---|---|
| 1 | Leslie Radvanyi | President and Scientific Director | $539,868 | +2.1% | 9/15722 | 1/7 |
| 2 | Christine Williams | Acting President and Head Implementation Science | $397,474 | +8.7% | 48/15722 | — |
| 3 | Lincoln Stein | Acting Scientific Director and Head Adaptive Oncology | $384,087 | +0.0% | 65/15722 | — |
| 4 | Jared Simpson | Interim Scientific Director and Principal Investigator | $333,375 | +23.6% | 197/15722 | — |
| 5 | David Uehling | Interim Scientific Director Therapeutic Innovation and Drug Discovery | $330,998 | +10.4% | 200/15722 | — |
| 6 | Peter Goodhand | Executive Lead | $322,162 | +0.0% | 218/15722 | — |
| 7 | Jeanette Dias Dsouza | Senior Vice President Group Chief Financial Officer | $321,472 | n/a | 220/15722 | 5/101 |
| 8 | Robert Campos | Senior Director | $257,961 | -2.3% | 510/15722 | — |
| 9 | Rebecca Tamarchak | Head Strategy Governance and Partnerships | $251,473 | +0.0% | 568/15722 | — |
| 10 | David Sutton | Senior Director | $241,870 | -1.3% | 643/15722 | — |